Personal tools
Contact the Department

Department of Cardiovascular Sciences
University of Leicester
Clinical Sciences Wing
Glenfield General Hospital
Leicester
LE3 9QP

General Enquiries to
Louise Goddard
Tel: 0116 258 3045

Postgraduate General Enquiries to
Postgraduate Tutor

For other contact details see under
Research Groups
People A-Z

 

Dr Joan E Davies

Dr Joan Davies
Honorary Senior Lecturer in Medicine & Therapeutics, University of Leicester and Consultant Physician, Cardiovascular Unit, University Hospitals of Leicester NHS Trust

BSc, Cardiff, 1978
MB BCh, Cardiff, 1984
PhD, Cardiff, 1981
FRCP, London, 1998

Tel: 0116 252 3126

Email: jed13@le.ac.uk

Address: Department of Cardiovascular Sciences, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, LE2 7LX

For general enquiries, please email Mrs Val Thomas or telephone 252 3126

Research Interests

  • Studies on the role of cardiovascular peptides in heart disease

  • The use of hormonal markers for diagnosis and prognosis in heart disease and to determine therapeutic response to various drug treatments

  • Echocardiography imaging and stress echocardiography

  • Evaluation of Prosthetic Valve dynamics

Key Publications

Kelly D, Khan SQ, Dhillon O, Quinn P, Struck J, Squire IB, Davies JE, Ng LL. Procalcitonin as a prognostic marker in patients with acute myocardial infarctionBiomarkers. 2010 Jun 15 4 325-31

Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) studyJ Am Coll Cardiol. 2008 May 13 51 19 1857-64

Khan SQ, Dhillon O, Struck J, Quinn P, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) StudyAm Heart J. 2007 Oct 154 4 736-42

Khan SQ, Quinn P, Davies JE, Ng LL. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarctionHeart. 2008 Jan 94 1 40-3

Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) studyCirculation. 2007 Apr 24 115 16 2103-10

Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies JE, Bergmann A, Ng LL. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) studyJ Am Coll Cardiol. 2007 Apr 10 49 14 1525-32

Ng LL, Pathik B, Loke IW, Squire IB, Davies JE. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failureAm Heart J. 2006 Jul 152 1 94-101

Ng LL, Loke IW, Davies JE, Geeranavar S, Khunti K, Stone MA, Chin DT, Squire IB. Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptidesJ Am Coll Cardiol. 2005 Apr 5 45 7 1043-50

Links

Recent Papers